Risk-adapted BEACOPP regimen can reduce the cumulative dose of chemotherapy for standard and high-risk Hodgkin lymphoma with no impairment of outcomeEldad J. Dann, Ron Epelbaum, Odelia Goor et al.|Blood|2006Cited by 124
A 10‐year experience with treatment of high and standard risk Hodgkin disease: Six cycles of tailored BEACOPP, with interim scintigraphy, are effective and female fertility is preservedEldad J. Dann, Ron Epelbaum, Zeev Blumenfeld et al.|American Journal of Hematology|2011Cited by 34
For Standard and High-Risk Patients with Hodgkin Lymphoma Six Cycles of Tailored BEACOPP, Based On Interim Scintigraphy, Are Effective and Female Fertility Is Preserved.Eldad J. Dann, Ron Epelbaum, Rachel Bar‐Shalom et al.|Blood|2009Cited by 3
Six Cycles of BEACOPP Tailored Based on Interim Scintigraphy Provide Favorable Outcome for Patients with Standard and Advanced Risk Hodgkin Lymphoma and Female Fertility Is Preserved: Results of a 10-Year Follow-upEldad J. Dann, Ron Epelbaum, Zeev Blumenfeld et al.|Blood|2011Cited by 0